T J Liesegang

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Varicella zoster virus vaccines: effective, but concerns linger
    Thomas J Liesegang
    Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 3224, USA
    Can J Ophthalmol 44:379-84. 2009
  2. ncbi Intracameral antibiotics: questions for the United States based on prospective studies
    Thomas J Liesegang
    Mayo Clinic, Jacksonville, Florida 32224, USA
    J Cataract Refract Surg 34:505-9. 2008
  3. ncbi Commercialism, loss of professionalism, and the effect on journals
    Thomas J Liesegang
    Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA
    Arch Ophthalmol 126:1292-5. 2008
  4. ncbi Revealing the faults in medical journals
    Thomas J Liesegang
    Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Arch Immunol Ther Exp (Warsz) 57:75-83. 2009
  5. ncbi Herpes simplex virus epidemiology and ocular importance
    T J Liesegang
    Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Cornea 20:1-13. 2001
  6. ncbi Use of antimicrobials to prevent postoperative infection in patients with cataracts
    T J Liesegang
    Consultant in Ophthalmology, Mayo Clinic, Jacksonville, Florida, USA
    Curr Opin Ophthalmol 12:68-74. 2001
  7. ncbi Varicella-zoster virus eye disease
    T J Liesegang
    Mayo Clinic Jacksonville, Florida 32224, USA
    Cornea 18:511-31. 1999
  8. ncbi Perioperative antibiotic prophylaxis in cataract surgery
    T J Liesegang
    Mayo Clinic Jacksonville, Florida 32224, USA
    Cornea 18:383-402. 1999
  9. ncbi Classification of herpes simplex virus keratitis and anterior uveitis
    T J Liesegang
    Department of Ophthalmology, Mayo Clinic Jacksonville, Florida 32224, USA
    Cornea 18:127-43. 1999
  10. ncbi Herpes zoster virus infection
    Thomas J Liesegang
    Mayo Clinic Medical School, Jacksonville, Florida, USA
    Curr Opin Ophthalmol 15:531-6. 2004

Collaborators

Detail Information

Publications36

  1. ncbi Varicella zoster virus vaccines: effective, but concerns linger
    Thomas J Liesegang
    Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 3224, USA
    Can J Ophthalmol 44:379-84. 2009
    ..The 2 vaccines are intertwined in the future epidemiology of VZV disease...
  2. ncbi Intracameral antibiotics: questions for the United States based on prospective studies
    Thomas J Liesegang
    Mayo Clinic, Jacksonville, Florida 32224, USA
    J Cataract Refract Surg 34:505-9. 2008
    ..A multipronged approach to limit endophthalmitis risk is also needed, with antibiotics as only part of the strategy...
  3. ncbi Commercialism, loss of professionalism, and the effect on journals
    Thomas J Liesegang
    Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA
    Arch Ophthalmol 126:1292-5. 2008
  4. ncbi Revealing the faults in medical journals
    Thomas J Liesegang
    Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Arch Immunol Ther Exp (Warsz) 57:75-83. 2009
    ..Readers need to scrutinize data in the literature carefully and interpret the discussions and conclusions critically, as there are biases in what is published in medical journals...
  5. ncbi Herpes simplex virus epidemiology and ocular importance
    T J Liesegang
    Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Cornea 20:1-13. 2001
    ..To review the changing epidemiology of herpes simplex disease and correlate it with the epidemiology of ocular herpes simplex disease...
  6. ncbi Use of antimicrobials to prevent postoperative infection in patients with cataracts
    T J Liesegang
    Consultant in Ophthalmology, Mayo Clinic, Jacksonville, Florida, USA
    Curr Opin Ophthalmol 12:68-74. 2001
    ..The worldwide problem of antibiotic resistance should temper our approach. Some organizational statements are reviewed, and personal recommendations are offered. Controversy still abounds...
  7. ncbi Varicella-zoster virus eye disease
    T J Liesegang
    Mayo Clinic Jacksonville, Florida 32224, USA
    Cornea 18:511-31. 1999
    ..To review the epidemiology, biology, systemic and ocular features, and treatment options for varicella zoster disease, including postherpetic neuralgia...
  8. ncbi Perioperative antibiotic prophylaxis in cataract surgery
    T J Liesegang
    Mayo Clinic Jacksonville, Florida 32224, USA
    Cornea 18:383-402. 1999
    ..To review the rationale for various methods of perioperative prophylaxis in elective cataract surgery...
  9. ncbi Classification of herpes simplex virus keratitis and anterior uveitis
    T J Liesegang
    Department of Ophthalmology, Mayo Clinic Jacksonville, Florida 32224, USA
    Cornea 18:127-43. 1999
    ..To review the classification of herpes simplex virus (HSV) keratitis and anterior uveitis using the available clinical, pathologic, and laboratory models of disease...
  10. ncbi Herpes zoster virus infection
    Thomas J Liesegang
    Mayo Clinic Medical School, Jacksonville, Florida, USA
    Curr Opin Ophthalmol 15:531-6. 2004
    ..Infection with VZV has different ramifications for people of different ages and immune status. The various aspects of VZV disease make it difficult to treat. Selected aspects of VZV disease that pertain to ocular disease are presented...
  11. ncbi Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity
    Thomas J Liesegang
    Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA
    Ophthalmology 115:S3-12. 2008
    ..The incidence and morbidity of herpes zoster (HZ) and HZ ophthalmicus (HZO), and the potential impact of varicella vaccine on their epidemiology...
  12. ncbi Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982
    T J Liesegang
    Department of Ophthalmology, Mayo Clinic, Rochester, Minn
    Arch Ophthalmol 107:1160-5. 1989
    ..Ninety percent of the eyes maintained visual acuity of 20/40 or better. The economic impact, measured in terms of days of active disease and physician visits, was substantial...
  13. ncbi A community study of ocular herpes simplex
    T J Liesegang
    Mayo Clinic Jacksonville, FL 32224
    Curr Eye Res 10:111-5. 1991
    ..This data estimates more accurately the morbidity and social impact of the condition...
  14. ncbi The outcome of manuscripts submitted to the American Journal of Ophthalmology between 2002 and 2003
    Thomas J Liesegang
    Department of Ophthalmology, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA
    Am J Ophthalmol 143:551-60. 2007
    ..To investigate the outcome of manuscripts submitted to the American Journal of Ophthalmology (AJO) between July 23, 2002 and December 31, 2003...
  15. ncbi Ophthalmic education: where have we come from, and where are we going?
    Thomas J Liesegang
    American Academy of Opthalmology, May Clinic Jacksonsonville, Florida 32224, USA
    Am J Ophthalmol 136:114-21. 2003
  16. ncbi The editorial process for medical journals: I. Introduction of a series and discussion of the responsibilities of editors, authors, and reviewers
    Thomas J Liesegang
    Am J Ophthalmol 136:109-13. 2003
  17. ncbi The Open Access initiative in scientific and biomedical publishing: fourth in the series on editorship
    Thomas J Liesegang
    Mayo Clinic Medical School, Jacksonville, Florida 32224, USA
    Am J Ophthalmol 139:156-67. 2005
    ....
  18. ncbi Chlamydia conjunctivitis and central retinal vein occlusion
    Michael W Stewart
    Department of Ophthalmology, Mayo Clinic College of Medicine, Jacksonville, FL 32082, USA
    Am J Ophthalmol 140:161-2. 2005
    ..To report a case of coexistent Chlamydia conjunctivitis and central retinal vein occlusion (CRVO) in which both problems improved significantly after oral doxycyline...
  19. ncbi Ocular herpes simplex infection: pathogenesis and current therapy
    T J Liesegang
    Department of Ophthalmology, Mayo Clinic Jacksonville, FL 32224
    Mayo Clin Proc 63:1092-105. 1988
    ..A plan for medical and surgical management of ocular herpes simplex, based on current knowledge of the disease process, relates to the integrity of the epithelium and the presence of active viral disease...
  20. ncbi Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis
    Ryan C Young
    Department of Ophthalmology, Mayo Clinic, 200 Rochester, MN 55905, USA
    Arch Ophthalmol 128:1178-83. 2010
    ..To provide an estimate of the incidence of herpes simplex virus (HSV) eye disease in a community-based cohort, and to investigate the effect of prophylactic oral antiviral therapy on HSV recurrences and outcomes...
  21. ncbi Biology and molecular aspects of herpes simplex and varicella-zoster virus infections
    T J Liesegang
    Mayo Clinic Jacksonville, FL 32224
    Ophthalmology 99:781-99. 1992
    ..There are multiple genes expressed during this latency. These features may explain the different clinical presentations and course of reactivation (zoster) compared with herpes simplex virus reactivation...
  22. ncbi Physiologic changes of the cornea with contact lens wear
    Thomas J Liesegang
    Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida 32224, USA
    CLAO J 28:12-27. 2002
    ..These changes vary with the specific lens style. The high-oxygen-permeable contact lenses recently introduced may overcome some of these problems...
  23. ncbi The American Journal of Ophthalmology announces online submission and peer review process
    Thomas J Liesegang
    Am J Ophthalmol 134:744-5. 2002
  24. ncbi How to ensure our readers' trust: the proper attribution of authors and contributors
    Thomas J Liesegang
    Am J Ophthalmol 146:337-40. 2008
  25. ncbi Pharmaceutical companies and ophthalmic research
    Thomas J Liesegang
    Ophthalmology 112:363-5. 2005
  26. ncbi Advantages and potential dangers of presentation before publication: third in a series on editorship
    Neil M Bressler
    Department of Ophthalmolgoy, The Johns Hopkins University School of Medicine, Baltimore, MD 21205-2002, USA
    Arch Ophthalmol 122:1045-8. 2004
  27. ncbi Meeting our ethical obligations in medical publishing: responsibilities of editors, authors, and readers of peer-reviewed journals
    Daniel M Albert
    Arch Ophthalmol 123:684-6. 2005
  28. ncbi The significance of the Edward Jackson lecture
    Thomas J Liesegang
    Am J Ophthalmol 139:530-2. 2005
  29. ncbi InternetAdvance: accelerated internet publication of articles and reports at ajo.com
    Bradley R Straatsma
    Am J Ophthalmol 133:551. 2002
  30. ncbi Maintaining public trust in medical journals
    Thomas J Liesegang
    Am J Ophthalmol 139:707-9. 2005
  31. ncbi Survey of ophthalmologists about ocular toxoplasmosis
    Flora Lum
    American Academy of Ophthalmology, San Francisco, California 94109 1336, USA
    Am J Ophthalmol 140:724-6. 2005
    ..To investigate the number of patient visits to ophthalmologists in the United States that are associated with ocular toxoplasmosis, and to assess ophthalmologists' knowledge and treatment practices with regard to the disease...
  32. ncbi Festschrift: a tribute to the accomplishments of Bradley R Straatsma, MD, JD
    Bruce E Spivey
    Am J Ophthalmol 136:106-8. 2003
  33. ncbi Safe and effective
    Andrew P Schachat
    Ophthalmology 110:2073-4. 2003
  34. ncbi Web 2.0, library 2.0, physician learning 2.0
    Thomas J Liesegang
    Ophthalmology 114:1801-3. 2007
  35. ncbi Registration of clinical trials
    Leonard A Levin
    Arch Ophthalmol 123:1263-4. 2005
  36. ncbi Institutional review boards and new patient privacy issues in publication
    Thomas J Liesegang
    Indian J Ophthalmol 55:169-71. 2007